Literature DB >> 19307755

Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential.

Arne Warth1, Esther Herpel, Sabine Krysa, Hans Hoffmann, Philipp A Schnabel, Peter Schirmacher, Gunhild Mechtersheimer, Hendrik Bläker.   

Abstract

Pulmonary carcinoids are infrequent neoplasms of the lung that normally display a less aggressive biological behavior compared to small cell and non-small cell lung cancers. Approximately 15-25% of carcinoids, in particular atypical carcinoids, show lymph node metastasis and have a worse prognosis than their non-metastasized counterparts. To date, there is no morphological or molecular marker that may help to differentiate between carcinoids that metastasize and carcinoids of identical differentiation that show only local tumor growth. In this study, we analyzed 7 metastasized and 10 non-metastasized pulmonary carcinoids for chromosomal and microsatellite instability in order to determine whether microsatellite instability or chromosomal imbalances are associated with metastasis. Due to the rare occurrence of metastasized carcinoids we compared our results of chromosomal instability with the hitherto published comparative genomic hybridization (CGH) profiles of pulmonary carcinoids, for which information about the absence or presence of metastasis was available. While microsatellite instability was not detected we found chromosomal instability as a common event in pulmonary carcinoids with an increase of frequency and extent of chromosomal alterations in atypical and metastasized carcinoids. These findings are in accordance with the collected and herein compiled data of previous studies and indicate increasing numbers of chromosomal imbalances to play a role in the sequential process of tumor development and metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19307755      PMCID: PMC2701984          DOI: 10.3858/emm.2009.41.5.039

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  17 in total

Review 1.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

2.  Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.

Authors:  Hendrik Bläker; Axel von Herbay; Roland Penzel; Stefanie Gross; Herwart F Otto
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

3.  Bronchial carcinoids. Review of 124 cases.

Authors:  B C McCaughan; N Martini; M S Bains
Journal:  J Thorac Cardiovasc Surg       Date:  1985-01       Impact factor: 5.209

4.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

5.  Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.

Authors:  K Hurr; B Kemp; S A Silver; A K el-Naggar
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

6.  The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues.

Authors:  Reinhard Ullmann; Susanna Petzmann; Huberta Klemen; Armando E Fraire; Phil Hasleton; Helmut H Popper
Journal:  Genes Chromosomes Cancer       Date:  2002-05       Impact factor: 5.006

7.  Pulmonary atypical carcinoid: predictors of survival in 106 cases.

Authors:  M B Beasley; F B Thunnissen; E Brambilla; P Hasleton; R Steele; S P Hammar; T V Colby; M Sheppard; Y Shimosato; M N Koss; R Falk; W D Travis
Journal:  Hum Pathol       Date:  2000-10       Impact factor: 3.466

8.  [CGH findings in neuroendocrine tumours of the lung].

Authors:  G Johnen; M Krismann; M Jaworska; K-M Müller
Journal:  Pathologe       Date:  2003-05-15       Impact factor: 1.011

9.  Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

Authors:  J Isola; S DeVries; L Chu; S Ghazvini; F Waldman
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors.

Authors:  Christian N Arnold; Takeshi Nagasaka; Ajay Goel; Iris Scharf; Patricia Grabowski; Andrea Sosnowski; Annette Schmitt-Gräff; C Richard Boland; Rudolf Arnold; Hubert E Blum
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

View more
  15 in total

Review 1.  [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 3.  Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

Authors:  Antonio Pea; Ralph H Hruban; Laura D Wood
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-28       Impact factor: 3.869

Review 4.  The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment.

Authors:  Samuel F Bakhoum; Lewis C Cantley
Journal:  Cell       Date:  2018-09-06       Impact factor: 41.582

Review 5.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

6.  Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Authors:  Dorian R A Swarts; Sandra M H Claessen; Yvonne M H Jonkers; Robert-Jan van Suylen; Anne-Marie C Dingemans; Wouter W de Herder; Ronald R de Krijger; Egbert F Smit; Frederik B J M Thunnissen; Cornelis A Seldenrijk; Aryan Vink; Aurel Perren; Frans C S Ramaekers; Ernst-Jan M Speel
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

7.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

Review 8.  [Novel morphological and molecular aspects of lung cancer].

Authors:  A Warth; A Stenzinger; W Weichert
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

9.  [S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation].

Authors:  A Warth; S Krysa; T Zahel; H Hoffmann; P Schirmacher; P A Schnabel; E Herpel
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

Review 10.  [Molecular pathology of lung cancer. State of the art 2014].

Authors:  A Warth; V Endris; R Penzel; W Weichert
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.